Acute Generalized Exanthematous Pustulosis with Erythema Multiforme‐Like lesions in a COVID‐19 woman

Autor:	Robustelli Test, E., Vezzoli, P., Carugno, A., Raponi, F., Gianatti, A., Rongioletti, F., Sena, P.
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	Drug reaction COVID‐19 viruses Acute Generalized Exanthematous Pustulosis (AGEP) virus diseases severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Letters to Editor Letter to Editor Hydroxychloroquine (HCQ) Skin
Zdroj:	Journal of the European Academy of Dermatology and Venereology
ISSN:	1468-3083 0926-9959
Popis:	The antimalarials, Chloroquine and Hydroxychloroquine (HCQ), and the antivirals Lopinavir/Ritonavir have been recently recorded as having anti‐severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) effects.1 In particular, regarding Italy, one of the countries most affected by the pandemic, the Italian Society of Infectious and Tropical disease (Lombardy section) has recommended the use of HCQ for treatment of coronavirus disease 2019 (COVID‐19).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::013abb683057454aacd5ac7c24aea04e http://europepmc.org/articles/PMC7272891 Zobrazit plný text záznamu Plný text